BUSINESSMARKETWATCH
AstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
AstraZeneca shares were declining while Bristol-Myers Squibb shares rose amid reported deal talks between the two pharmaceutical companies. Analysts are uncertain about the potential motivations for a partnership between the firms.
Related Signal
Adjacent reporting
- AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
- AstraZeneca holds talks with Bristol Myers Squibb over £300bn merger
- AstraZeneca Is Said to Have Explored Bristol Myers Merger
- AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
- AstraZeneca said to have explored Bristol Myers merger
- AstraZeneca Said to Have Explored Bristol Myers Merger